About Sandhill therapeutics, inc.
Sandhill Therapeutics, Inc. is a biotechnology company that specializes in developing innovative cellular immunotherapies for the treatment of cancer. The company's proprietary co-activation and expansion technology harnesses natural killer (NK) and innate T cells from healthy donors to create a powerful cytotoxic cellular immunotherapy with potent tumor-killing ability.
Sandhill's approach to cancer treatment is based on the idea that the body's own immune system can be harnessed to fight cancer. The company's technology involves isolating NK and innate T cells from healthy donors, activating them using Sandhill's proprietary co-activation technology, and expanding them in vitro to create a large population of highly potent cytotoxic cells.
The resulting cellular immunotherapy has been shown to be effective against a wide range of solid tumors, including lung cancer, breast cancer, ovarian cancer, pancreatic cancer, and colorectal cancer. In preclinical studies, Sandhill's therapy has demonstrated strong anti-tumor activity both as a monotherapy and in combination with other treatments such as checkpoint inhibitors.
One of the key advantages of Sandhill's approach is its ability to target multiple types of tumors simultaneously. Unlike traditional chemotherapy or radiation therapy which can damage healthy tissues along with tumor cells, Sandhill's therapy specifically targets tumor cells while leaving healthy tissues unharmed.
Sandhill Therapeutics was founded by a team of experienced biotech entrepreneurs who recognized the potential for cellular immunotherapies in oncology. The company has assembled an impressive team of scientists and clinicians who are dedicated to advancing this promising new approach to treating cancer.
In addition to its core research program focused on developing novel cellular immunotherapies for oncology indications, Sandhill also collaborates with academic institutions and other industry partners on various research projects aimed at advancing our understanding of the immune system and its role in fighting disease.
Overall, Sandhill Therapeutics represents an exciting new frontier in oncology research. With its innovative approach to harnessing the power of the immune system to fight cancer, the company is poised to make a significant impact on the field of cancer treatment and improve outcomes for patients around the world.